XML 30 R24.htm IDEA: XBRL DOCUMENT
v3.25.3

Description of Business - Additional Information (Details) - USD ($) $ in Thousands |  | 6 Months Ended |
--- | --- | --- | ---
Mar. 25, 2025 | Sep. 30, 2025 | Mar. 31, 2025
Description Of Business And Summary Of Significant Accounting Policies [Line Items] |  |  |
Escrow receivable |  | $ 1,008 | $ 1,000
Period of escrow | 15 months |  |
Minimum [Member] |  |  |
Description Of Business And Summary Of Significant Accounting Policies [Line Items] |  |  |
Percentage of Drug Candidate |  | 10.00% |
Metacrine, Inc. [Member] |  |  |
Description Of Business And Summary Of Significant Accounting Policies [Line Items] |  |  |
Upfront payment paid | $ 10,000 |  |
Closing upfront payment | 9,000 |  |
Escrow receivable | 1,000 |  |
Metacrine, Inc. [Member] | Metacrine's FXR Program [Member] |  |  |
Description Of Business And Summary Of Significant Accounting Policies [Line Items] |  |  |
Upfront payment paid | 10,000 |  |
Closing upfront payment | 9,000 |  |
Escrow receivable |  |  | $ 1,000
Future milestone | $ 50,000 |  |

X
- Definition The designation of funds furnished by a borrower to a lender to assure future payments of the borrower's real estate taxes and insurance obligations with respect to a mortgaged property. Escrow deposits may be made for a variety of other purposes such as earnest money and contingent payments. This element excludes replacement reserves which are an escrow separately provided for within the US GAAP taxonomy. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 942 -SubTopic 210 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-03(10)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 954 -SubTopic 440 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478522/954-440-50-1 + Details
Name: | us-gaap_EscrowDeposit
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Closing upfront payment paid. + References No definition available. + Details
Name: | vivs_ClosingUpfrontPaymentPaid
Namespace Prefix: | vivs_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Description of business and summary of significant accounting policies. + References No definition available. + Details
Name: | vivs_DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesLineItems
Namespace Prefix: | vivs_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Future milestones payment. + References No definition available. + Details
Name: | vivs_FutureMilestonesPayment
Namespace Prefix: | vivs_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Percentage of drug candidate. + References No definition available. + Details
Name: | vivs_PercentageOfDrugCandidate
Namespace Prefix: | vivs_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Period of escrow. + References No definition available. + Details
Name: | vivs_PeriodOfEscrow
Namespace Prefix: | vivs_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Upfront payment paid. + References No definition available. + Details
Name: | vivs_UpfrontPaymentPaid
Namespace Prefix: | vivs_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Details
Name: | srt_RangeAxis=srt_MinimumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RelatedPartyTransactionAxis=vivs_MetacrineIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AssetAcquisitionAxis=vivs_MetacrinesFxrProgramMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |